Shorted
Echoiq logo
EIQ

Echoiq

Software & Services

Echoiq specializes in prescriptive artificial intelligence solutions, focusing on enhancing decision-making processes in various industries. The company leverages advanced AI technologies to provide actionable insights, positioning itself as a leader in the AI-driven software market.

Short position

short percentage3.31%
reported shorts24.5M
shares on issue740.875M

Echoiq (ASX:EIQ) has 3.31% of its shares on issue reported as short positions as of 5 Oct 2026, or about 24,510,428 shares. Over the past 30 days that figure has risen 2.96 percentage points, and over 90 days it has risen 3.04 percentage points. EIQ is classified in the Software & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

Echoiq (EIQ) News

Latest articles and price-sensitive announcements with AI sentiment classification.

Kalkine
Positive
24 Sept

Is Echo IQ (ASX:EIQ) the AI Stock to Watch as Global Growth Signals Shift?

Highlights Energy and rate moves are creating a different market setup from a routine trading day. Echo IQ Ltd sits within the AI-linked shares conversation as sector rotation becomes more visible. The central watchpoints are commercial adoption and delivery discipline and the quality of company communication. The local market opens into a demanding global setup, with rates, energy and risk appetite all moving at once. Echo IQ Ltd (ASX:EIQ) therefore enters the session with attention likely t...

Continue reading
Kalkine
Neutral
22 Sept

What Does the FDA Setback Mean for Echo IQ (ASX:EIQ)?

Highlights Echo IQs EchoSolv HF application received a Not Substantially Equivalent determination from the US FDA, creating a regulatory hurdle for the heart-failure product. The company says the FDA feedback relates to aspects of the statistical analysis supporting clinical validation rather than the underlying technology or core functionality. Echo IQ is assessing several regulatory pathways while its existing EchoSolv AS product remains FDA-cleared for use in the United States. Echo IQ Limi...

Continue reading
Kalkine
Neutral
17 Sept

Why Is Echo IQ (ASX:EIQ) Drawing Attention Today?

Highlights Echo IQ is in focus after a fresh regulatory application update. The update keeps attention on digital cardiology and clinical decision support and the companys next operational steps. The broader Healthcare Stocks theme remains centred on execution, disclosure quality and strategic follow-through. Further company updates will help clarify how todays development fits into the longer operating pathway. Echo IQ (ASX:EIQ) is drawing attention today after a fresh regulatory application...

Continue reading
Kalkine
Neutral
14 Sept

EchoIQ Grants 2 Million Unlisted Options to Non-Executive Director as Part of Remuneration Package

EchoIQ Limited (ASX:EIQ) has granted 2,000,000 unlisted options to a Non-Executive Director as remuneration under a Letter of Appointment, as detailed in an Appendix 3G filing dated 14 September 2026. Key Points 2,000,000 unlisted options issued on 1 September 2026 as remuneration for a Non-Executive Director Options carry an exercise price of $1.24 each and expire on 1 September 2029 Securities were issued without cash consideration and are not intended to be listed on the ASX Upon exercise,...

Continue reading
Kalkine
Neutral
9 Sept

Echo IQ Brings Execution Pathway to Market (ASX:EIQ)

Highlights Echo IQ has placed execution pathway at the centre of current market scrutiny through its recent filing. The update directs attention toward funding access, milestone delivery and trading liquidity without removing the need for careful evidence review. Equity interpretation depends on delivery quality, clear reporting and alignment between strategy, funding and operating conditions. Echo IQ (ASX:EIQ) has drawn attention during the latest completed Australian market session after re...

Continue reading
Kalkine
Neutral
4 Sept

EchoIQ Announces Termination of 500,000 Employee Options Effective September 2026

EchoIQ Limited (ASX:EIQ) has informed the ASX about the termination of 500,000 unquoted employee options under the security code EIQAAU. This action follows the lapse of conditional rights, as the required conditions were either unmet or became impossible to fulfill, with the termination effective from 4 September 2026. Key Points 500,000 options under security code EIQAAU terminated on 4 September 2026 Termination due to conditions not being met or becoming impossible to satisfy No payment o...

Continue reading
Kalkine
Neutral
1 Sept

EchoIQ Limited Files Initial Director's Interest Notice for Newly Appointed Director Scott Wilkin

EchoIQ Limited (ASX:EIQ) has submitted an Initial Director's Interest Notice with the ASX revealing the securities holdings of Mr Scott Wilkin, who joined the company’s board as a director on 1 September 2026. Key Points Scott Wilkin was officially appointed as a director of EchoIQ Limited effective 1 September 2026. Mr Wilkin directly holds 2,000,000 unlisted options, as detailed in Part 3 of the notice. These options have an exercise price of $1.24 and expire three years after their issue...

Continue reading
Kalkine
Neutral
7 July

Why Is EchoIQ (ASX:EIQ) Quoting New Shares on the ASX?

Highlights EchoIQ has applied to quote newly issued ordinary shares on the ASX. The quotation expands the company's listed share base and supports ongoing capital markets activity. The update reflects capital structure management rather than a new operational announcement. EchoIQ Limited (ASX:EIQ) has announced an application to the Australian Securities Exchange (ASX) for the quotation of newly issued ordinary fully paid shares. The application formalises the admissi...

Continue reading